Clinical Trial Update: A Study of Recombinant Human Albumin Injection to Treat Hypoalbuminemia in Cirrhotic Patients With Ascites [Phase 3]

View source ↗

Summary

This document provides an update on a Phase 3 trial evaluating recombinant human albumin injections to treat hypoalbuminemia in cirrhotic patients with ascites,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis of the Liver
• Hepatic Ascites

Drugs mentioned

• Recombinant Human Albumin Injection (recombinant human albumin)

Snippet

Sponsor: Tonghua Anrate Biopharmaceutical Co., Ltd. | Conditions: Hepatic Ascites | Phase 3 | Status: COMPLETED